Frail patients had higher p16INK4a expression with median 0.042 (0.035-0.047) vs. 0.039 (0.033-0.046), p<0.01 (Figure 1A); after adjustment for groups (BC and HCT), p=0.33. This evidence concerns the gene CDKN2A and breast cancer.